Cargando…
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
BACKGROUND: Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are characterised by abnormal epigenetic repression and differentiation of bone marrow haematopoietic stem cells (HSCs). Drugs that reverse epigenetic repression, such as 5-azacytidine (5-AZA), induce haematological improv...
Autores principales: | Kazachenka, Anastasiya, Young, George R., Attig, Jan, Kordella, Chrysoula, Lamprianidou, Eleftheria, Zoulia, Emmanuela, Vrachiolias, George, Papoutselis, Menelaos, Bernard, Elsa, Papaemmanuil, Elli, Kotsianidis, Ioannis, Kassiotis, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929315/ https://www.ncbi.nlm.nih.gov/pubmed/31870430 http://dx.doi.org/10.1186/s13073-019-0707-x |
Ejemplares similares
-
Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter
por: Kordella, Chryssoula, et al.
Publicado: (2021) -
Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
por: Mitroulis, Ioannis, et al.
Publicado: (2023) -
The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes
por: Kazachenka, Anastasiya, et al.
Publicado: (2023) -
Soluble PD-L1 generated by endogenous retroelement exaptation is a receptor antagonist
por: Ng, Kevin W, et al.
Publicado: (2019) -
P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
por: Dimitriou, Despoina, et al.
Publicado: (2023)